Kdpt

1 study on Kdpt curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Kdpt. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Kdpt studies and clinical research

2026-04-03 PubMed · in vitro · n preclinical

KPV tripeptide retains α-MSH anti-inflammatory potency without pigmentary side effects

**KPV and KdPT reframe the anti-inflammatory potential of α-MSH by stripping it down to a receptor-independent, pigmentation-free tripeptide** — a meaningful leap for any clinician or researcher frustrated by full-hor…

Research tools

Free, no account — handy when you're working with Kdpt.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$14 monthly or $88/year

Create an account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Kdpt studies and clinical research

KPV tripeptide retains α-MSH anti-inflammatory potency without pigmentary side effects

Research tools